Atlas Trials

TCC

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch TCC

RecordFirmDate
The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer (NCT04671407)Kaplan Medical Center2021-01-20
Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection (NCT04147182)Dan Leibovici2018-12-02

Track TCC automatically

Every clearance here is in the API, with alerts when new ones post.